Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ball Drops On Pfizer's New Year's Eve-Themed Ads For Viagra

This article was originally published in The Pink Sheet Daily

Executive Summary

AIDS Healthcare Foundation urges Pfizer to curb "irresponsible" advertising for its erectile dysfunction drug.

The AIDS Healthcare Foundation is urging Pfizer to discontinue consumer ads encouraging the use of Viagra on New Year's Eve because the campaign promotes use of the erectile dysfunction therapy as a "party drug." The Los Angeles-based advocacy group released a statement Dec. 30 criticizing Pfizer's recent ad campaign.

"Not only does sending this reckless message contribute to the spread of sexually transmitted diseases, but it is also part of a pattern of irresponsible direct-to-consumer advertising by the drug industry," foundation President Michael Weinstein said.

The ad in question ran in several publications, including The Wall Street Journal and The New York Times, leading up to New Year's Eve. The ad depicts a smiling man with the tagline, "What are you doing New Year's Eve?"

In addition, the ad includes the reminder, "Fact: Viagra can help guys with all degrees of erectile dysfunction - from mild to severe." The statement implies that "having a medical condition is not necessarily a prerequisite to being prescribed the drug," the AIDS Healthcare Foundation said.

A recent HHS conference on the topic, however, concluded that current data on risky behaviors does not support a labeling change.

Pfizer's marketing strategy for Viagra (sildenafil) has come under fire in the past. Last year, Pfizer halted its "Wild Thing" TV campaign for Viagra after FDA objected to it (1 (Also see "Viagra "Wild Thing" Ads Too Wild For FDA; Pfizer Will Pull Them" - Pink Sheet, 15 Nov, 2004.)).

In part due to criticism of such ads, the Pharmaceutical Research & Manufacturers of America has adopted a new voluntary DTC advertising policy in an effort encourage more responsible, educational Rx advertising. The guidelines go into effect Jan. 1, though it is unclear whether Pfizer's piece would be permitted under them.

As part of the policy, broadcast ads for erectile dysfunction drugs were restricted to times when at least 80% of viewers are over 18 years of age (2 (Also see "PhRMA Board Gives Preliminary Nod To Voluntary DTC Guidelines" - Pink Sheet, 21 Jul, 2005.)).

Erectile dysfunction drug makers, including Pfizer and Cialis makers Lilly/Icos, have vowed to take an even more hard-lined approach to future ads.

-Jonathan Block

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS061469

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel